Please assess the completion status of the following clinical trial:

Trial Title: Transcutaneous Raman Spectroscope (TRS) Analyses of Diabetic Foot Ulcers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Ability to provide informed consent~* Diagnosis of diabetes mellitus~* Full thickness or superficial foot and ankle ulcers based on clinical assessment (e.g., University of Texas (UT) grades 1-3, stages A-D). For reference, see Appendix 1 for the UT classification table~Exclusion Criteria:~* Age less than 18 or greater than 80 years old~* Subject has a psychological or sociological condition or an addictive disorder that would preclude informed consent~* Completely epithelialized ulcer based on clinical assessment with no ischemia or infection (UT classification 0A)~* Current or previous use of anti-resorptive bisphosphonate drugs (e.g., risedronate (Actonel) and alendronate (Fosamax))

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- TRS (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).